Breaking News
Sort by:
Date
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Aardvark Therapeutics, Inc., Completes $29m Series B Funding Led by Sorrento Therapeutics and Including Existing Investors and the Foundation for Prader-Willi Research
Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing and commercializing novel small […]
- Halozyme Appoints Barbara Duncan to its Board of Directors Read more
- Dianosic Raises €4.7M to Bring Treatment for Chronic Rhinitis into Clinical Trial Read more
- Clexio and Genetika+ Announce Partnership Using Proprietary Antidepressant Screening Platform Read more
- Mihir Patel Joins Cambia Health Solutions as Chief Pharmacy Officer Read more
- Sandoz Biologics License Application for Proposed Biosimilar Denosumab Accepted by US FDA Read more